These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27181179)

  • 1. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
    Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
    Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
    Vinberg M; Miskowiak K; Hoejman P; Pedersen M; Kessing LV
    PLoS One; 2015; 10(5):e0127629. PubMed ID: 26011424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
    Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
    Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
    Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
    Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
    Trials; 2010 Oct; 11():97. PubMed ID: 20942940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
    Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
    Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders.
    Vinberg M; Højman P; Pedersen BK; Kessing LV; Miskowiak KW
    Acta Neuropsychiatr; 2018 Dec; 30(6):342-349. PubMed ID: 29880069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
    Miskowiak KW; Macoveanu J; Vinberg M; Assentoft E; Randers L; Harmer CJ; Ehrenreich H; Paulson OB; Knudsen GM; Siebner HR; Kessing LV
    Acta Psychiatr Scand; 2016 Sep; 134(3):249-59. PubMed ID: 27259062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
    Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
    J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
    J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
    Ott CV; Vinberg M; Kessing LV; Miskowiak KW
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder.
    Miskowiak KW; Petersen NA; Harmer CJ; Ehrenreich E; Kessing LV; Vinberg M; Macoveanu J; Siebner HR
    Acta Psychiatr Scand; 2018 Oct; 138(4):336-347. PubMed ID: 29882276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    Psychiatry Res; 2018 Nov; 269():207-211. PubMed ID: 30153598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial.
    Miskowiak KW; Forman JL; Vinberg M; Siebner HR; Kessing LV; Macoveanu J
    J Psychiatry Neurosci; 2020 May; 45(3):198-205. PubMed ID: 31804779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.